| Position | Action |
|---|---|
| At issuance (no trigger needed) | 60% of target weight |
| Neither price trigger fires by Q4 FY26 earnings (late January 2027) | Trim regardless of price |
| Daily close below 10 EMA at $363.97 on volume | Tactical caution flag - do not add |
| Daily close below 200 SMA at $329.87 | Hard stop - exit position |
Visa is a best-in-class compounder that just completed its most aggressive strategic pivot in a decade, combining double-digit revenue re-acceleration with deliberate moat reinforcement through BioCatch, stablecoin rails, and agent commerce positioning—while returning $23B+ annually to shareholders and trading in confirmed uptrend alignment.
| Indicator | Value | Signal |
|---|---|---|
| close | 368.54 | — |
| open | 372.30 | — |
| high | 372.40 | — |
| low | 366.72 | — |
| volume | 6062771 | — |
| 10_ema | 364.80 | bullish |
| 50_sma | 342.71 | bullish |
| 200_sma | 329.87 | bullish |
| rsi | 64.25 | bullish |
| boll_upper | 373.69 | — |
| boll_mid | 360.05 | — |
| boll_lower | 346.41 | — |
| macd | 7.02 | — |
| macd_signal | 7.04 | — |
| macd_histogram | -0.02 | bearish |
| atr | 8.17 | — |
| vwma_60 | 362.68 | bullish |
Support: 364.8 · 360.05 · 355 · 346.41 · 342.71 · 329.87 | Resistance: 373.69 · 370 · 390
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Active HOLD on V: 60% sizing with dual price triggers and mandatory calendar re-evaluation gate to prevent passive alpha drag
This HOLD is explicitly active, not passive. The 60% sizing at issuance protects against the failure branch (vs. prior full Holds that drifted into alpha drag). The calendar gate at Q4 FY26 earnings forces a binary decision: either BioCatch integration validates the cost trajectory and scales toward Overweight, or cost-of-revenue continues compounding at 30%+ and we trim. Key risks include cost-of-revenue acceleration (+39% YoY), margin compression (operating income declined 5.7% Q2→Q3), and valuation at 31x trailing/24.6x forward P/E with RSI at 64 near upper Band after 22% rally. The secular thesis ($23B annual capital return, BioCatch, Arc mainnet, stablecoin rails) remains intact but warrants reduced sizing until momentum confirms.
When: Confirmed close above $375 on volume ≥10-12M shares
Then: Add to position
The moat is being deliberately reinforced across multiple vectors—BioCatch ($2.4B cash at 85% premium) positions Visa as the identity/authentication layer for agent commerce, while stablecoin strategy hedges every plausible rails scenario via Circle Arc, Zerohash, Visa Direct, and Western Union partnership.
↩ rebuts: “Bear claim that BioCatch was an expensive acquisition and stablecoins will cannibalize Visa”
· concedes: Stock trades at 31.4x trailing earnings; Near 52-week highs; MACD histogram is marginally negative (-0.02); RSI at 64.25 approaching overbought
Visa at $368.54 is a value trap masquerading as a compounder—paying 31x trailing earnings for margin compression, a speculative $2.4B acquisition, and a technical setup 7.5% extended above the 50 SMA with negative MACD momentum, offering no margin of safety for new buyers.
· concedes: BioCatch could eventually prove valuable if agent commerce scales over 5-10 years; Visa's stablecoin strategy shows some awareness of the blockchain threat; Visa remains the dominant card network with significant scale advantages; The MACD negative signal doesn't guarantee an immediate crash—consolidation could occur
→ vs conservative: Wait for $340-350 pullback narrative is misguided; stock already rallied 25% from $294 to $368 between March and now, and waiting for comfortable pullback levels that may never materialize is how investors underperform
→ vs conservative: Margin compression argument is a 'sequential snapshot distortion'; 61% operating margin and 66% full-year margin with record revenue and operating income represent elite-tier fortress profitability, not deterioration
→ vs neutral: RSI at 64 is not 'approaching overbought' (overbought is 70); Visa has spent most of the last decade trading at RSI 50-75 during its secular uptrend
→ vs neutral: MACD histogram at -0.02 is a microscopic negative tick that routinely happens in strong trends; the MACD line at 7.02 remains massively positive
→ vs neutral: Interpretation of Klarman's Mastercard purchase as negative for Visa is a 'complete misread'; buying the duopoly sector signals elite value investors view both payment networks as mispriced versus risk profile
→ vs neutral: Waiting for a 'guidance miss' that may never come is the real risk given stable consumer spending, falling recession odds, and strong upcoming catalysts (Arc mainnet, Q4 earnings)
Visa is in a strong bullish trend after recovering +22% from its March 2026 low of ~$294 to current levels near $368.54. All three moving averages are stacked bullishly (10 EMA > 50 SMA > 200 SMA) with price above each, confirming a textbook bullish alignment. The RSI at 64.25 is constructive but approaching overbought territory above 70, and the MACD histogram has turned marginally negative at -0.02, signaling early momentum cooling at the margin without contradicting the broader trend. Price is positioned in the upper third of the Bollinger envelope, approximately 88% of the way to the upper band at $373.69, with the VWMA (60-day) at $362.68 confirming the rally is supported by genuine volume participation. Risk management recommends ATR-based stops with a standard stop around $356.28 (1.5× ATR of $8.17), with the overall trade bias favoring pullback entries into the $360-$365 zone over chasing at current extended levels.
Market Cap
$688.08 B
P/E Ratio (TTM)
31.4x
Forward P/E
24.6x
PEG Ratio
1.66
Price/Book
19.5x
EPS (TTM)
$11.75
Forward EPS
$14.97
Dividend Yield
0.73%
Beta
0.76
52-Week High
$373.97
52-Week Low
$293.89
50-Day MA
$341.14
200-Day MA
$330.39
Revenue (TTM)
$44.49 B
Gross Profit
$43.48 B
EBITDA
$31.09 B
Net Income (TTM)
$22.40 B
Profit Margin
50.8%
Operating Margin
66.1%
ROE
61.2%
ROA
19.1%
Free Cash Flow
$20.40 B
FY2025 Revenue
$40.00 B
FY2025 Operating Revenue
$51.70 B
FY2025 Gross Profit
$32.15 B
FY2025 Operating Income
$26.56 B
FY2025 Net Income
$20.06 B
FY2025 Diluted EPS
$10.20
FY2025 Operating Margin
66.4%
FY2024 Revenue
$35.93 B
FY2024 Operating Revenue
$46.49 B
FY2024 Gross Profit
$28.88 B
FY2024 Operating Income
$24.06 B
FY2024 Net Income
$19.74 B
FY2024 Diluted EPS
$9.73
FY2024 Operating Margin
67.0%
FY2023 Revenue
$32.65 B
FY2023 Operating Revenue
$42.47 B
FY2023 Gross Profit
$26.09 B
FY2023 Operating Income
$21.93 B
FY2023 Net Income
$17.27 B
FY2023 Diluted EPS
$8.28
FY2023 Operating Margin
67.1%
FY2022 Revenue
$29.31 B
FY2022 Operating Revenue
$37.61 B
FY2022 Gross Profit
$23.58 B
FY2022 Operating Income
$19.68 B
FY2022 Net Income
$14.96 B
FY2022 Diluted EPS
$7.00
FY2022 Operating Margin
67.1%
Q3 FY26 Total Revenue
$11.63 B
Q3 FY26 Operating Revenue
$14.82 B
Q3 FY26 Operating Income
$7.13 B
Q3 FY26 Net Income
$5.63 B
Q3 FY26 Diluted EPS
$2.97
Q2 FY26 Total Revenue
$11.23 B
Q2 FY26 Operating Revenue
$14.16 B
Q2 FY26 Operating Income
$7.56 B
Q2 FY26 Net Income
$6.02 B
Q2 FY26 Diluted EPS
$3.14
Q1 FY26 Total Revenue
$10.90 B
Q1 FY26 Operating Revenue
$13.96 B
Q1 FY26 Operating Income
$7.45 B
Q1 FY26 Net Income
$5.85 B
Q1 FY26 Diluted EPS
$3.03
Q4 FY25 Total Revenue
$10.72 B
Q4 FY25 Operating Revenue
$13.80 B
Q4 FY25 Operating Income
$7.05 B
Q4 FY25 Net Income
$5.09 B
Q4 FY25 Diluted EPS
$2.62
Q3 FY25 Total Revenue
$10.17 B
Q3 FY25 Operating Revenue
$13.12 B
Q3 FY25 Operating Income
$6.79 B
Q3 FY25 Net Income
$5.27 B
Q3 FY25 Diluted EPS
$2.69
TTM Revenue
$44.49 B
TTM EPS
$11.76
Revenue 3-Year CAGR
~10.9%
EPS Growth FY22 to FY25
+45.7%
Q3 FY26 YoY Revenue Growth
+14.4%
Q3 FY26 YoY EPS Growth
+10.4%
FY25 Total Assets
$99.63 B
FY25 Total Liabilities
$61.72 B
FY25 Stockholders' Equity
$37.91 B
FY25 Total Debt
$25.17 B
FY25 Net Debt
$8.01 B
FY25 Cash & Equivalents
$17.16 B
FY25 Goodwill + Intangibles
$47.53 B
FY25 Current Ratio
0.99
FY25 Debt/Equity
67.8
FY25 Operating Cash Flow
$23.06 B
FY25 CapEx
$1.48 B
FY25 Free Cash Flow
$21.58 B
FY25 Share Repurchases
$18.32 B
FY25 Dividends Paid
$4.63 B
FY25 Acquisitions
$0.89 B
FY25 FCF Margin
~54%
FCF Yield
~2.97%
FY25 Net Margin
50.1%
Distance from 50-Day MA
+3.7%
Distance from 200-Day MA
+7.1%
Annual Dividend Per Share
$2.36
Q3 FY26 Dividend Paid
$1.273 B
Strengths
Concerns
Visa Inc. is a high-quality compounder with best-in-class fundamentals including 66.1% operating margin, 61.2% ROE, and consistent ~10.9% revenue CAGR, underpinned by a fortress duopoly moat and asset-light network model. The company generates exceptional cash flow ($21.58B FY25 FCF) and returns capital aggressively through $18.32B annual buybacks and growing dividends. At 31.4x P/E near 52-week highs, the stock is richly valued but supported by durable secular tailwinds and 27% expected EPS growth. Best suited for long-term holders; tactical traders should await pullbacks toward the 50-day MA (~$341) or 200-day MA (~$330) for improved risk/reward.